Common γ-chain cytokines (IL-2, 4, 7, 9, 15, 21) and X-SCID
- Molecule
Six cytokines share one receptor part, the common γ chain; lose that single part and a baby is born without T cells and NK cells.
What it is
IL-2, IL-4, IL-7, IL-9, IL-15 and IL-21 each have their own receptor chain but share the common γ chain (γc, CD132), encoded by IL2RG on the X chromosome. The γc signals through JAK3, while the private chain uses JAK1. Because IL-7 is needed for T cells and IL-15 for NK cells, a γc or JAK3 defect causes severe combined immunodeficiency with no T or NK cells. JAK inhibitors used in rheumatology act on this pathway.
Step by step
- The cytokine binds its private receptor chain and the common γ chain.
- JAK1 on the private chain and JAK3 on γc phosphorylate each other and the receptor tails.
- STAT proteins dock, are phosphorylated, pair up and move to the nucleus.
- Target genes for survival, proliferation and differentiation are switched on.
- SOCS proteins induced by the same signal later switch it off.
The common γ-chain family
| Cytokine | Main source | Main effect | Main STAT |
|---|---|---|---|
| IL-2 | Activated T cells | T-cell proliferation; survival and function of regulatory T cells | STAT5 |
| IL-4 | Th2, Tfh, mast cells | Th2 differentiation; switch to IgE and IgG4 | STAT6 |
| IL-7 | Marrow and thymic stroma | T-cell (and early lymphoid) development; naive and memory T survival | STAT5 |
| IL-9 | Th9, mast cells, ILC2 | Mast-cell growth, mucus production | STAT5 |
| IL-15 | Macrophages, dendritic cells, epithelium | NK-cell development and survival; CD8 memory T cells | STAT5 |
| IL-21 | Tfh, Th17 | B-cell differentiation into plasma cells; germinal centres | STAT3 |
Clinical notes
- X-linked SCID (IL2RG): the most common SCID; T⁻ B⁺ NK⁻; B cells are present but cannot make antibody without T-cell help and IL-21.
- JAK3 deficiency gives the same picture but is autosomal recessive, so girls can be affected.
- IL-7 receptor α deficiency: T⁻ B⁺ NK⁺, because IL-15 signalling to NK cells is intact.
- JAK inhibitors (for example tofacitinib, baricitinib, upadacitinib) treat RA and other inflammatory diseases; they raise the risk of infections such as herpes zoster.
- Early gene therapy trials for X-SCID worked but some children developed leukaemia from vector insertion; newer vectors are designed to avoid this.
Common traps
- X-SCID has no B cells: B cells are present (T⁻ B⁺ NK⁻) but useless without T-cell help and IL-21 signalling.
- Only boys get this SCID picture: JAK3 deficiency gives the same phenotype and is autosomal recessive, so girls can have it.
- IL-7Rα deficiency looks exactly like X-SCID: NK cells are present (T⁻ B⁺ NK⁺) because IL-15 signalling is untouched.
- The γ chain is part of the IL-2 receptor only: it serves IL-2, IL-4, IL-7, IL-9, IL-15 and IL-21, which is why losing it is so severe.
Test yourself
Think of the answer, then tap the question to see it.
Why does X-linked SCID lack NK cells as well as T cells?
The common γ chain is part of the IL-15 receptor, which NK cells need, as well as the IL-7 receptor needed by T cells.
A girl has T⁻ B⁺ NK⁻ SCID. Which gene is most likely affected and why not IL2RG?
JAK3, autosomal recessive; IL2RG is X-linked, so a girl would usually be a carrier rather than affected.
Why do patients on JAK inhibitors get more herpes zoster?
Blocking JAK signalling dampens γ-chain cytokines such as IL-15 and IL-2 and interferons that sustain antiviral NK and T cells.
Elsewhere in DurgiPedia
Connections
In Pharmacology1
Educational content on the immune system; not a treatment or individual vaccination guide and no substitute for a health professional's advice. No doses are given.
Sources: IL2RG gene (MedlinePlus Genetics, US National Library of Medicine, 2024); X-linked severe combined immunodeficiency (MedlinePlus Genetics, US National Library of Medicine, 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
